🇮🇳 India Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

Star Health and Allied Insurance Company Limited STARHEALTH NIFTY_SMALLNSEFINANCIAL

Financial Services · Insurance - Life · India
https://www.starhealth.in
Company Profile ↓
₹557.35
+25.29% 1Y
Mkt Cap₹32,794.67 Cr
P/E58.85
P/B3.31
52W High₹610.40
52W Low₹425.15
Book Value₹128.33
EPS (TTM)₹9.47

Company Overview

Star Health and Allied Insurance Company Limited provides health insurance products in India. It offers retail health insurance products for individuals, families, children, senior citizens, and persons with pre-existing medical conditions; group health insurance products for employer/employee and non-employer/employee groups, including small-to-medium enterprises; and personal accident and travel insurance products. The company also provides star women care insurance policy that provides surrogacy and oocyte donor covers; and star special care product that covers children diagnosed with autism and for outpatient specialized treatments. In addition, it offers star health assure insurance policy, star cancer care platinum insurance policy, senior citizens health insurance policy, and star cardiac care insurance policy – platinum, as well as star group OPD care insurance product. The company offers its products through web aggregators, digital channels, agency channels, corporate agents, brokers, point of salesperson, insurance marketing firms, and various other channels. Star Health and Allied Insurance Company was incorporated in 2005 and is based in Chennai, India.

Why Investors Should Care

Steady Revenue Expansion

Revenue has grown at a 14.0% CAGR over the past five years.

Conservative Balance Sheet

Carries low leverage with a debt-to-equity ratio of 0.06.

Positive Free Cash Flow

Generates positive free cash flow, funding growth and shareholder returns internally.

Recent Developments

  • Mar 2026 Revenue of ₹18,148.47 Cr (+10.1% YoY); net profit ₹556.98 Cr.
  • Trailing 12 Months Year-on-year growth — revenue +10.1%, earnings -13.8%.
  • 5-Year Trend Long-term compounding — revenue CAGR 14.0%, profit CAGR -3.4%.

Growth & Price Performance

Compounded Sales Growth

5 Years:14.03%
1 Year:10.07%

Compounded Profit Growth

5 Years:-3.44%
1 Year:-13.76%

Stock Price Performance

1 Year:+25.29%
6 Months:+21.47%
3 Months:+6.89%
1 Month:-2.84%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Mixed
52-Week Range 71% of range
₹425.15 ₹610.40
Trend Signals
  • Price vs 50-DMABelow
  • Price vs 200-DMAAbove
  • RSI (14)36.18 · Neutral
Price Performance
1M-2.84%
3M+6.89%
6M+21.47%
1Y+25.29%
Valuation vs Sector

P/E of 58.85 is above the sector median of 19.62 — pricier than peers.

Auto-generated from price history and fundamentals; not investment advice.

Ad space

Price Chart

NSE TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Compounding revenue at 14.0% over 5 years.
  • Generates positive free cash flow.
  • In a confirmed uptrend (50-DMA above 200-DMA).

CONS

  • Trading at a high P/E of 58.9.
  • Earnings shrank at -3.4% CAGR over 5 years.

* The pros and cons are auto-generated from financial metrics.

Ad space

Valuation

Stock P/E
58.85
Industry PE
19.62
Forward P/E
19.25
PEG Ratio
-
Book Value
₹128.33
Price to Book
3.31
P/S
1.81
EV/EBITDA
-
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
14.03%
Profit 5Y
-3.44%
Revenue (YoY)
10.07%
Earnings (YoY)
-13.76%

Profitability & Returns

ROCE
-
ROE
7.38%
ROA
2.31%
Profit Margin
3.07%
Op Margin
4.51%
Gross Margin
21.95%
EPS (Latest Qtr)
₹9.33
EPS (TTM)
₹9.47

Balance Sheet & Liquidity

Debt/Equity
0.06
Quick Ratio
-
Current Ratio
-
Debt
₹470.00 Cr
Total Assets
₹23,780.04 Cr
Current Assets
-
Working Capital
-

Ownership

Promoter Holding
65.74%
Chg in Prom Hold
1.63%
FII / Inst Holding
24.25%
Chg in FII Hold
0.15%

Financial Snapshot

Enterprise Value
₹32,794.67 Cr
Total Revenue (TTM)
₹18,148.47 Cr
EBITDA
-
Free Cash Flow
₹1,795.34 Cr
Operating Cash Flow
-
Shares Outstanding
₹58.84 Cr
Gross Margin
21.95%
Payout Ratio
0.00%

Peer comparison

Peer companies in the same sector (Financial Services).

#NameCMP ₹P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 STARHEALTH Star Health and Allied Insurance Company Limited NIFTY_SMALLNSEFINANCIAL 557.35 58.85 ₹32,794.67 Cr 0.00% - 7.38% 14.03% -3.44%
2 HDFCBANK HDFC Bank Limited NIFTY50NSEAIFINANCIAL 712.10 15.57 ₹10.96 L Cr 1.77% - 8.63% 16.90% 12.47%
3 ICICIBANK ICICI Bank Limited NIFTY50NSEAIFINANCIAL 1,423.20 19.03 ₹10.19 L Cr 0.82% - 14.93% 18.11% 16.78%
4 SBIN State Bank of India NIFTY50NSEAIFINANCIALPSU 1,016.10 11.15 ₹9.38 L Cr 1.60% - 13.97% 12.19% 14.39%
5 BAJFINANCE Bajaj Finance Limited NIFTY50NSEAIFINANCIAL 1,060.50 34.76 ₹6.60 L Cr 0.47% - 16.68% 22.58% 18.23%
6 LICI Life Insurance Corporation of India NIFTY_MIDNSEFINANCIALPSU 415.35 9.14 ₹5.25 L Cr 2.58% - 32.53% 7.26% 16.86%
7 KOTAKBANK Kotak Mahindra Bank Limited NIFTY50NSEAIFINANCIAL 424.50 21.89 ₹4.22 L Cr 0.16% - 10.64% 13.48% 8.92%
8 AXISBANK Axis Bank Limited NIFTY50NSEAIFINANCIAL 1,273.00 15.07 ₹3.96 L Cr 0.08% - 12.27% 12.16% 34.61%
9 BAJAJFINSV Bajaj Finserv Ltd. NIFTY50NSEAIFINANCIAL 1,970.00 32.30 ₹3.15 L Cr 0.06% - 12.58% 22.92% 15.16%
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in INR.

Metric Sep 2024Dec 2024Mar 2025Jun 2025Dec 2025Mar 2026Jun 2026
Revenue --4,081.13 Cr4,692.58 Cr4,566.62 Cr4,648.16 Cr5,285.44 Cr
Cost of Revenue -------
Gross Profit -------
Operating Expenses -------
Operating Income ---602.28 Cr--754.52 Cr
EBITDA -------
Interest Expense ---14.20 Cr--12.82 Cr
Pretax Income ---87.00 L588.08 Cr173.42 Cr151.21 Cr741.70 Cr
Tax Provision ---1.38 Cr149.90 Cr45.20 Cr39.87 Cr191.97 Cr
Net Income --51.00 L438.18 Cr128.22 Cr111.34 Cr549.73 Cr
Diluted EPS --0.017.452.181.899.33

Profit & Loss (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue -12,241.10 Cr14,413.32 Cr16,488.13 Cr18,148.47 Cr
Cost of Revenue -----
Gross Profit -----
Operating Expenses -----
Operating Income -1,348.25 Cr914.82 Cr1,208.99 Cr926.47 Cr818.39 Cr
EBITDA -----
Interest Expense 48.38 Cr88.42 Cr80.14 Cr65.42 Cr64.06 Cr
Pretax Income -826.40 Cr1,128.85 Cr861.05 Cr754.33 Cr
Tax Provision -207.81 Cr283.84 Cr215.19 Cr197.34 Cr
Net Income -618.59 Cr845.01 Cr645.86 Cr556.98 Cr
Diluted EPS -10.4114.1910.869.47

Balance Sheet (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets -16,357.72 Cr18,054.33 Cr20,784.62 Cr24,063.76 Cr
Current Assets -----
Cash & Equivalents -309.36 Cr444.58 Cr668.43 Cr1,443.56 Cr
Inventory -----
Receivables -3.15 Cr40.69 Cr53.39 Cr231.18 Cr
Total Liabilities -9,768.83 Cr11,322.54 Cr13,672.48 Cr16,512.54 Cr
Current Liabilities -----
Long Term Debt -470.00 Cr470.00 Cr470.00 Cr470.00 Cr
Total Debt -470.00 Cr470.00 Cr470.00 Cr470.00 Cr
Total Equity -6,588.89 Cr6,731.79 Cr7,112.14 Cr7,551.22 Cr
Shares Outstanding -58.17 Cr58.53 Cr58.78 Cr58.84 Cr

Cash Flows (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow -----
Investing Cash Flow --1,097.13 Cr-1,176.71 Cr-1,150.58 Cr-1,066.85 Cr
Financing Cash Flow --268.02 Cr22.97 Cr-4.20 Cr-31.48 Cr
Capital Expenditure --46.59 Cr-123.49 Cr-82.71 Cr-78.11 Cr
Free Cash Flow -1,229.22 Cr1,186.47 Cr1,295.91 Cr1,795.34 Cr
Net Change in Cash --89.33 Cr156.22 Cr223.84 Cr775.12 Cr

Ratios (Annual)

Figures in %.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Margin % -----
Operating Margin % -7.5%8.4%5.6%4.5%
Net Margin % -5.1%5.9%3.9%3.1%
ROE % -9.4%12.6%9.1%7.4%
ROCE % -----

Shareholding Pattern

Insiders
65.74%
Institutions
24.25%
Public Float
70.78%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for STARHEALTH

Google News Mon, 07 Sep 2026

Star Health Share Price today: Rs 572, sector and peers - Univest

<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxQc3E4Vzh4QnpmcHhrYzFMekZrQmgtLThDSDVFQW9POHJvb2lLZjRkeWtnYXFlSVJGb1ZCTGRNTDVzalk2S2Q0d3g4Y2x0U3NMdzNrX1NwcUI0NzhjWS1sUVIxZkR0TmJram5PWUptQWRQSks5TUtORUxlSWU3LTJIcTUxRFY3UnNncGhDRn…

Google News hu, 30 Jul 2026

Earnings call transcript: Star Health posts stronger q1 2026 profit, shares rise - Investing.com

<a href="https://news.google.com/rss/articles/CBMizwFBVV95cUxQeGhOR1JoSkt2QmRzc29ZUFNXa1lIM042bHU0b21HM0E5a29PNlVlVk83ZnJ6Wk5XODltZWh3aEJwSEE2WnJ1cXl3bWxVek5yLUJFSjJBUmoxcTJwX2JIVm9qX0pwZGw4cWhDbWh5NFRLdDJXNFFIbDdwNUNHMlp3Skx1aWs1aDZuUjZGSX…

Google News Mon, 03 Aug 2026

Star Health and Allied Insurance Company Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - simplywall.st

<a href="https://news.google.com/rss/articles/CBMi9AFBVV95cUxNZWlYZnhNLS00WE5nZEdZc3g2X2pEOTNuX0VYYVhxeVVlNWRHeWN6Z3NZalhLTEZUaFJycEh4THRmc1kzMHFzLU5tcmdMV083ejg2Nkh0dDNTRG5yUVhTRXMxMHlIMDVTRkJILTdVNU8xQTBhMTh2SUIzVDRXTFRhcDNzNHhBQVhrV203WE…

Google News Fri, 04 Sep 2026

Star Health & Allied Insurance Share Price - Live NSE: STARHEALTH Stock Price & Chart - Upstox

<a href="https://news.google.com/rss/articles/CBMib0FVX3lxTE1ock1NSnBYVTR5QTRxWkQ2MlZFOThKZ2JGUThUMlp6QnZVWTZZZGFUX3lUY0tyY0VkTElrU3BmQ1REUW84UXpDeF83SWpjVE5pQXc5WVdhaDdLa1YyNzJLLV9nZWRBa1pJeUstS0tDMA?oc=5" target="_blank">Star Health & All…

Google News Fri, 14 Aug 2026

Stock Radar: Star Health stock slips from July 2026 52-week high, but bounces back from 50-DMA; time to bu - The Economic Times

<a href="https://news.google.com/rss/articles/CBMiigJBVV95cUxNNGJXT1h1UTQ4Y2RDMnc3UHBjU3pPRkE4MDM2Z1NYQXFnLUYxX2FpemhuYXFYbElaQ09fTGs0WC1ZMzhBeDUxbTB2cWQtOUkxLXRCTWRTNXBRQ0hTMGMxTTBPbUpyb3ZkUVhNWUhHeEZzUE84R3JlQjJEckxua2pBSU5uLUp6RXZFSnVQU2…

Google News hu, 13 Aug 2026

Star Health hosts analyst meet with East Bridge Capital on Aug 25 - scanx.trade

<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxNd0ZsMUhyNGNQQTRUVlRwekgtQU5KaXhpZU8wYWNhNUt6S1phanJGZVdoN0k5cFBqQXR0em04NHIySnRZR1VXU2NBSmZndjgxVW94OHVVMjhCcnJVMmlldGQ3bDV5cHVnQWtRcThiam44T2ZDV3lvdGViUVItZWdWbHRfNFdUQmRMY1Z3WF…

STARHEALTH — Frequently Asked Questions

What is the current share price of Star Health and Allied Insurance Company Limited (STARHEALTH)?

As of 2026-09-08 04:53 IST, Star Health and Allied Insurance Company Limited (STARHEALTH) trades at ₹557.35 on NSE. Its 52-week range is ₹425.15 to ₹610.40.

What is the market capitalisation of STARHEALTH?

Star Health and Allied Insurance Company Limited (STARHEALTH) has a market capitalisation of ₹32,794.67 Cr on NSE.

What is the P/E ratio of STARHEALTH?

STARHEALTH trades at a trailing price-to-earnings (P/E) ratio of 58.85. The industry average P/E is 19.62. Its price-to-book (P/B) ratio is 3.31.

What is the return on equity (ROE) of STARHEALTH?

STARHEALTH has a return on equity (ROE) of 7.38%.

Is STARHEALTH a good stock to buy?

This page provides a data-driven analysis of Star Health and Allied Insurance Company Limited (STARHEALTH), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Financial Services Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All India Stocks